BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12750824)

  • 1. [Incompatibility reactions in the intensive care unit. Five years after the implementation of a simple "colour code system"].
    Vogel Kahmann I; Bürki R; Denzler U; Höfler A; Schmid B; Splisgardt H
    Anaesthesist; 2003 May; 52(5):409-12. PubMed ID: 12750824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provision of pharmaceutical care in the intensive care unit.
    Kilroy RA; Iafrate RP
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):221-5. PubMed ID: 8398030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Justification and operation of a critical-care satellite pharmacy.
    Caldwell RD; Tuck BA
    Am J Hosp Pharm; 1983 Dec; 40(12):2141-5. PubMed ID: 6660227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bar code documentation of pharmacotherapy services in intensive care units.
    Zarowitz BJ; Petitta A; Rudis MI; Horst HM; Hyzy R
    Pharmacotherapy; 1996; 16(2):261-6. PubMed ID: 8820470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a safer approach to intravenous drug infusions: failure mode effects analysis.
    Apkon M; Leonard J; Probst L; DeLizio L; Vitale R
    Qual Saf Health Care; 2004 Aug; 13(4):265-71. PubMed ID: 15289629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of intravenous drug incompatibilities in an intensive care unit.
    Bertsche T; Mayer Y; Stahl R; Hoppe-Tichy T; Encke J; Haefeli WE
    Am J Health Syst Pharm; 2008 Oct; 65(19):1834-40. PubMed ID: 18796425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A primer on critical care pharmacy services.
    Erstad BL
    Ann Pharmacother; 2008 Dec; 42(12):1871-81. PubMed ID: 19017823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug interactions in practice].
    Hoppe-Tichy T; Simon K; Hentze BW
    Ther Umsch; 2000 Sep; 57(9):563-7. PubMed ID: 11036436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Errors in preparation and administration of intravenous medications in the intensive care unit of a teaching hospital: an observational study.
    Fahimi F; Ariapanah P; Faizi M; Shafaghi B; Namdar R; Ardakani MT
    Aust Crit Care; 2008 May; 21(2):110-6. PubMed ID: 18387813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing adverse events in the pediatric intensive care unit: prospectively targeting factors that lead to intravenous potassium chloride order errors.
    White JR; Veltri MA; Fackler JC
    Pediatr Crit Care Med; 2005 Jan; 6(1):25-32. PubMed ID: 15636655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous admixture service: implementation of service in a complex ICU patient population.
    Roof PS
    Hosp Pharm; 1989 Aug; 24(8):633-6, 638. PubMed ID: 10294359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key articles and guidelines relative to intensive care unit pharmacotherapy: 2009 update.
    Erstad BL; Brophy GM; Martin SJ; Haas CE; Devlin JW; Welage LS; Dager WE
    Pharmacotherapy; 2009 Oct; 29(10):1228-69. PubMed ID: 19792995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive care telemedicine: evaluating a model for proactive remote monitoring and intervention in the critical care setting.
    Groves RH; Holcomb BW; Smith ML
    Stud Health Technol Inform; 2008; 131():131-46. PubMed ID: 18305328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication reconciliation in a rural trauma population.
    Miller SL; Miller S; Balon J; Helling TS
    Ann Emerg Med; 2008 Nov; 52(5):483-91. PubMed ID: 18550221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay.
    Marshall J; Finn CA; Theodore AC
    Crit Care Med; 2008 Feb; 36(2):427-33. PubMed ID: 18091554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug incompatibilities in intravenous therapy: evaluation and proposition of preventive tools in intensive care and hematology units.
    Maison O; Tardy C; Cabelguenne D; Parat S; Ducastelle S; Piriou V; Lepape A; Lalande L
    Eur J Clin Pharmacol; 2019 Feb; 75(2):179-187. PubMed ID: 30543036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation of a compatibility chart for intravenous drug therapy in neonatal and pediatric intensive care units].
    Höpner JH; Schulte A; Thiessen J; Knuf M; Huth RG
    Klin Padiatr; 2007; 219(1):37-43. PubMed ID: 17205430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of computerized physician order entry on clinical practice in a newborn intensive care unit.
    Cordero L; Kuehn L; Kumar RR; Mekhjian HS
    J Perinatol; 2004 Feb; 24(2):88-93. PubMed ID: 14872207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the implementation of a clinical information system decrease the time intensive care nurses spend on documentation of care?
    Saarinen K; Aho M
    Acta Anaesthesiol Scand; 2005 Jan; 49(1):62-5. PubMed ID: 15675984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.